OM
Healthcare & Life Sciences

OMEICOS

OMEICOS is a Healthcare & Life Sciences startup based in Germany.

Active

About OMEICOS

OMEICOS is a company headquartered in Germany. Brouky classifies it under Healthcare & Life Sciences.

OMEICOS develops therapies targeting mitochondrial, cardiovascular, and inflammatory diseases by leveraging omega-3 fatty acid metabolism; its lead compound OMT-28 is advancing into Phase 3 clinical trials for Primary Mitochondrial Disease.

Explore OMEICOS's full profile on Brouky

Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.

Other Startups in Germany